DCM
RAPT

Dupont Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Dupont Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-980
Closed -$172K – 1732
2022
Q1 		$172K Buy
980
+269
+38% +$50.8K 0.01% 1111
2021
Q4 		$209K Buy
+711
New +$190K 0.01% 1098

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Dupont Capital Management's RAPT Position: Q2 2022 in Review

Dupont Capital Management sold out of RAPT Therapeutics (RAPT) in Q2 2022, closing a stake of 980 shares — an estimated $172K sold.

Dupont Capital Management first reported a position in RAPT in Q4 2021 and held it in 2 quarters. The position peaked at $209K in Q4 2021. 84 funds tracked by Wall St. Rank hold RAPT as of Q2 2022.

  • Dupont Capital Management reported no remaining RAPT Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Dupont Capital Management sold 980 RAPT Therapeutics shares in Q2 2022, an estimated $172K.
  • Dupont Capital Management first reported a position in RAPT Therapeutics in Q4 2021 and held it in 2 quarters.
  • Dupont Capital Management's RAPT Therapeutics position peaked at $209K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.